{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:27:53Z","timestamp":1792787273995,"version":"4.5.0"},"reference-count":37,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"unspecified","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute for Health and Care Research Health Technology Assessment programme","award":["NIHR152506"],"award-info":[{"award-number":["NIHR152506"]}],"id":[{"id":"https:\/\/ror.org\/0187kwz08","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,8,19]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Head injury in older adults is increasingly common, often caused by low-impact falls. A significant proportion of these patients are taking oral anticoagulants (OACs) to prevent stroke or thromboembolism. When traumatic bleeding within the head occurs, OACs are usually stopped to reduce the risk of worsening haemorrhage; however, prolonged interruption increases the risk of stroke, systemic thromboembolism and death. There is currently no consensus on when it is safest to restart OACs. Direct oral anticoagulants (DOACs) are now widely prescribed and may offer advantages over warfarin. This trial aims to determine the safest and most effective timing to start\/restart a DOAC after a traumatic intracranial haemorrhage (tICH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a phase III, multi-centre, randomised controlled trial. Adults with tICH who were taking an OAC before injury will be recruited across approximately 20 trauma networks in the UK. Eligible participants will be randomised to restart DOAC therapy either 1\u2009week or 4 weeks after tICH. The primary outcome is the proportion of patients with a haemorrhagic or thrombotic event within 12 weeks of tICH. Secondary outcomes include time-to-first haemorrhagic or thrombotic event, survival, functional status, quality of life and health resource use. Follow-up will occur at 6, 12 and 26 weeks, with data analysed on an intention-to-treat basis. Health economic and qualitative sub-studies will run alongside the main trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study addresses a major area of clinical uncertainty. By directly comparing 1-week versus 4-week re-initiation of OAC, this trial will provide robust evidence to guide clinical practice in a tICH population at high risk of both bleeding and thrombotic complications. Findings will inform patient counselling, acute care protocols and guideline development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination section<\/jats:title>\n                    <jats:p>Ethical approval has been obtained from the Berkshire Research Ethics Committee (24\/SC\/0298). Written informed consent will be obtained from all participants or their legal representatives before enrolment. Findings will be disseminated through peer-reviewed publications, scientific conferences, trial registry reporting and patient-facing summaries, with the aim of informing future guidance on anticoagulation management following tICrH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial results\" xlink:href=\"NCT06322953\">NCT06322953<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-121224","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:45:20Z","timestamp":1789645520000},"page":"e121224","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Timing to restart direct oral anticoagulants after traumatic intracranial haemorrhage (RESTART tICrH): study protocol for a randomised controlled multicentre trial"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct06322953","registry":"10.18810\/clinical-trials-gov","type":"results"}],"author":[{"given":"Ellie","family":"Edlmann","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, University of Plymouth, Plymouth, UK"},{"name":"South West Neurosurgical Centre, University Hospitals Plymouth NHS Trust, Plymouth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8703-4859","authenticated-orcid":false,"given":"Siddarth","family":"Kannan","sequence":"additional","affiliation":[{"name":"Neurosurgery, Walton Centre for Neurology and Neurosurgery, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Wright","sequence":"additional","affiliation":[{"name":"Liverpool Clinical Trials Centre, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Hardwick","sequence":"additional","affiliation":[{"name":"Liverpool Clinical Trials Centre, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Brown","sequence":"additional","affiliation":[{"name":"Liverpool Clinical Trials Centre, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Gornall","sequence":"additional","affiliation":[{"name":"Liverpool Clinical Trials Centre, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"McLoughlin","sequence":"additional","affiliation":[{"name":"Emergency Department, Royal Liverpool University Hospital, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Haunton","sequence":"additional","affiliation":[{"name":"Faculty of Health, Plymouth University, Plymouth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8816-9008","authenticated-orcid":false,"given":"Yankier","family":"Pijeira Perez","sequence":"additional","affiliation":[{"name":"Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8247-7459","authenticated-orcid":false,"given":"Dyfrig A","family":"Hughes","sequence":"additional","affiliation":[{"name":"Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nic","family":"Vine","sequence":"additional","affiliation":[{"name":"Public and Patient Involvement representatives, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Grantham","sequence":"additional","affiliation":[{"name":"Public and Patient Involvement representatives, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truman J","family":"Milling","sequence":"additional","affiliation":[{"name":"University of Texas at Austin Dell Seton Medical Center, Austin, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5604-9378","authenticated-orcid":false,"given":"Deirdre A","family":"Lane","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK"},{"name":"Liverpool Centre for Cardiovascular Science, Liverpool John Moores University, Liverpool, UK"},{"name":"Aalborg Universitet, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science, Liverpool John Moores University, Liverpool, UK"},{"name":"Aalborg Universitet, Aalborg, Denmark"},{"name":"University of Bialystok, Bialystok, Podlaskie Voivodeship, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Jenkinson","sequence":"additional","affiliation":[{"name":"Neurosurgery, Walton Centre for Neurology and Neurosurgery, Liverpool, UK"},{"name":"University of Liverpool Institute of Systems Molecular and Integrative Biology, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J","family":"McMahon","sequence":"additional","affiliation":[{"name":"Neurosurgery, Northern Care Alliance NHS Foundation Trust, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"2026091704451363000_16.9.e121224.1","unstructured":"Banerjee J , Baxter M , Coats T , et al . Major trauma in older people. Manchester Trauma Audit & Research Network (TARN); 2017. Available: https:\/\/www.gmccmt.org.uk\/wp-content\/uploads\/2019\/11\/Major-Trauma-in-Older-People-2017-1.pdf"},{"key":"2026091704451363000_16.9.e121224.2","unstructured":"Ageing. United Nations. Available: https:\/\/www.un.org\/en\/global-issues\/ageing [Accessed 10 Mar 2026]."},{"key":"2026091704451363000_16.9.e121224.3","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6537a2"},{"key":"2026091704451363000_16.9.e121224.4","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2023.100797","article-title":"Atrial fibrillation: stroke prevention","volume":"37","author":"Chao","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"2026091704451363000_16.9.e121224.5","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1055\/a-2595-5575","article-title":"Patient Care Pathways and Risk Assessments in Patients with Atrial Fibrillation: A Comparison of Asian versus Non-Asian Cohorts","volume":"125","author":"Chang","year":"2025","journal-title":"Thromb Haemost"},{"key":"2026091704451363000_16.9.e121224.6","unstructured":"Edlmann E , Whitfield P . Recommencement of anti-thrombotics in elderly head injury; a survey of UK practice. Society of British Neurosurgeons Spring Meeting, 2021."},{"key":"2026091704451363000_16.9.e121224.7","doi-asserted-by":"crossref","DOI":"10.1136\/tsaco-2020-000605","article-title":"Restarting and timing of oral anticoagulation after traumatic intracranial hemorrhage: a review and summary of ongoing and planned prospective randomized clinical trials","volume":"5","author":"King","year":"2020","journal-title":"Trauma Surg Acute Care Open"},{"key":"2026091704451363000_16.9.e121224.8","doi-asserted-by":"publisher","DOI":"10.1055\/a-1400-6159"},{"key":"2026091704451363000_16.9.e121224.9","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1161\/STROKEAHA.122.038752","article-title":"Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage: Systematic Review and Meta-Analysis","volume":"53","author":"Ivany","year":"2022","journal-title":"Stroke"},{"key":"2026091704451363000_16.9.e121224.10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1055\/a-2496-5492","article-title":"Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF Trial","volume":"125","author":"Korompoki","year":"2025","journal-title":"Thromb Haemost"},{"key":"2026091704451363000_16.9.e121224.11","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1016\/j.wneu.2017.10.165","article-title":"Readmissions in Patients with Anticoagulated Intracranial Hemorrhage: A Retrospective Review","volume":"110","author":"DiFiori","year":"2018","journal-title":"World Neurosurg"},{"key":"2026091704451363000_16.9.e121224.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033357","article-title":"Has the introduction of direct oral anticoagulants (DOACs) in England increased emergency admissions for bleeding conditions? A longitudinal ecological study","volume":"10","author":"Alfirevic","year":"2020","journal-title":"BMJ Open"},{"key":"2026091704451363000_16.9.e121224.13","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euab065"},{"key":"2026091704451363000_16.9.e121224.14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"The Lancet"},{"key":"2026091704451363000_16.9.e121224.15","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.clinthera.2017.05.358","article-title":"Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses","volume":"39","author":"Almutairi","year":"2017","journal-title":"Clin Ther"},{"key":"2026091704451363000_16.9.e121224.16","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1111\/bcp.15464","article-title":"Effectiveness and safety of intracranial events associated with the use of direct oral anticoagulants for atrial fibrillation: A systematic review and meta-analysis of 92 studies","volume":"88","author":"Archontakis-Barakakis","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"2026091704451363000_16.9.e121224.17","doi-asserted-by":"publisher","DOI":"10.1055\/a-1789-4824"},{"key":"2026091704451363000_16.9.e121224.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.08.005"},{"key":"2026091704451363000_16.9.e121224.19","doi-asserted-by":"crossref","unstructured":"MichaelHuberman A , B.Miles M , Ritchie J , et al . Qualitative Data Analysis for Applied Policy Research. The Qualitative Researcher\u2019s Companion 2002;305\u201329. doi:10.4135\/9781412986274.n12","DOI":"10.4135\/9781412986274.n12"},{"key":"2026091704451363000_16.9.e121224.20","doi-asserted-by":"publisher","DOI":"10.1055\/a-1400-6159"},{"key":"2026091704451363000_16.9.e121224.21","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.598540"},{"key":"2026091704451363000_16.9.e121224.22","doi-asserted-by":"publisher","DOI":"10.1089\/neu.1998.15.573"},{"key":"2026091704451363000_16.9.e121224.23","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.613273"},{"key":"2026091704451363000_16.9.e121224.24","doi-asserted-by":"publisher","DOI":"10.5770\/cgj.23.463"},{"key":"2026091704451363000_16.9.e121224.25","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"2026091704451363000_16.9.e121224.26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/02688697.2019.1710825","article-title":"Rationalising neurosurgical head injury referrals: development and validation of the Liverpool Head Injury Tomography Score (Liverpool HITS) for mild TBI","volume":"34","author":"Gillespie","year":"2020","journal-title":"Br J Neurosurg"},{"key":"2026091704451363000_16.9.e121224.27","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081477","article-title":"SPIRIT 2025 statement: updated guideline for protocols of randomised trials","volume":"389","author":"Chan","year":"2025","journal-title":"BMJ"},{"key":"2026091704451363000_16.9.e121224.28","unstructured":"NHS England . National cost collection for the NHS. Available: https:\/\/www.england.nhs.uk\/costing-in-the-nhs\/national-cost-collection\/ [Accessed 10 Mar 2026]."},{"key":"2026091704451363000_16.9.e121224.29","unstructured":"Unit costs 2022-2027. Care and Outcomes Research Centre. Available: https:\/\/research.kent.ac.uk\/corec\/unit-costs-2022-2027\/ [Accessed 10 Mar 2026]."},{"key":"2026091704451363000_16.9.e121224.30","unstructured":"National Institute for Health and Care Excellence . NICE technology appraisal and highly specialised technologies guidance: the manual. NICE; 2022."},{"key":"2026091704451363000_16.9.e121224.31","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s40273-016-0485-x","article-title":"Methodological Issues Surrounding the Use of Baseline Health-Related Quality of Life Data to Inform Trial-Based Economic Evaluations of Interventions Within Emergency and Critical Care Settings: A Systematic Literature Review","volume":"35","author":"Dritsaki","year":"2017","journal-title":"Pharmacoeconomics"},{"key":"2026091704451363000_16.9.e121224.32","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/tpj.2016.41","article-title":"Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden","volume":"16","author":"Verhoef","year":"2016","journal-title":"Pharmacogenomics J"},{"key":"2026091704451363000_16.9.e121224.33","unstructured":"LCTC . Research. Available: https:\/\/lctc.org.uk\/ [Accessed 5 Jul 2026]."},{"key":"2026091704451363000_16.9.e121224.34","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1055\/a-2068-6464","article-title":"Anticoagulant Management and Outcomes in Nontraumatic Intracranial Hemorrhage Complicated by Venous Thromboembolism: A Retrospective Chart Review","volume":"123","author":"Gorman","year":"2023","journal-title":"Thromb Haemost"},{"key":"2026091704451363000_16.9.e121224.35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/jamainternmed.2016.9369","article-title":"Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation","volume":"177","author":"Nielsen","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2026091704451363000_16.9.e121224.36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1814051"},{"key":"2026091704451363000_16.9.e121224.37","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx598"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-121224","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:45:27Z","timestamp":1789645527000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-121224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,17]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/bmjopen-2026-121224"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-121224","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}